| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A fluid-powered refillable origami heart pouch for minimally invasive delivery of cell therapies in rats and pigs
|
Mei, Xuan
|
|
|
|
11 |
p. 1253-1268.e4
|
artikel
|
| 2 |
A multi-country analysis of COVID-19 hospitalizations by vaccination status
|
Gonçalves, Bronner P.
|
|
|
|
11 |
p. 797-812.e2
|
artikel
|
| 3 |
Cardiorenal mechanisms of action of glucagon-like-peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors
|
Cherney, David Z.I.
|
|
|
|
11 |
p. 1203-1230
|
artikel
|
| 4 |
Delayed fractional dosing with RTS,S/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies
|
Das, Jishnu
|
|
|
|
11 |
p. 1269-1286.e9
|
artikel
|
| 5 |
Determining a multimodal aging clock in a cohort of Chinese women
|
Li, Jiaming
|
|
|
|
11 |
p. 825-848.e13
|
artikel
|
| 6 |
Evaluating human mutation databases for “treatability” using patient-customized therapy
|
Mittal, Swapnil
|
|
|
|
11 |
p. 740-759
|
artikel
|
| 7 |
Exportin(g) precision oncology beyond genomics with XPO1 inhibition
|
Gouda, Mohamed A.
|
|
|
|
11 |
p. 730-732
|
artikel
|
| 8 |
Fields to fermentors: Brewing botanical chemotherapeutic precursors using genetically engineered yeast
|
Srinivasan, Prashanth
|
|
|
|
11 |
p. 727-729
|
artikel
|
| 9 |
Health burden of unbalanced fatty acids intake from 1990 to 2019: A global analysis
|
Hu, Jun-Jie
|
|
|
|
11 |
p. 778-796.e3
|
artikel
|
| 10 |
Healthy and sustainable diets
|
|
|
|
|
11 |
p. 723-726
|
artikel
|
| 11 |
IPSOS trial: A “game changer” redefining first-line immunotherapy in platinum-ineligible NSCLC
|
García-Pardo, Miguel
|
|
|
|
11 |
p. 745-748
|
artikel
|
| 12 |
LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency
|
O’Connor, Marie N.
|
|
|
|
11 |
p. 1231-1252.e10
|
artikel
|
| 13 |
Multidrug-resistant mutations to antiviral and antibody therapy in an immunocompromised patient infected with SARS-CoV-2
|
Hirotsu, Yosuke
|
|
|
|
11 |
p. 813-824.e4
|
artikel
|
| 14 |
Now you see me, now you don’t: New approaches to sparing nonmalignant cells from CAR T cell therapies
|
Petty, Nicholas E.
|
|
|
|
11 |
p. 749-751
|
artikel
|
| 15 |
One size fits all: The story of SGLT2 inhibitors in heart failure
|
Verma, Subodh
|
|
|
|
11 |
p. 735-739
|
artikel
|
| 16 |
RNase-H-mediated silencing in the CNS proves predictably nontrivial
|
Moazami, Michael P.
|
|
|
|
11 |
p. 733-734
|
artikel
|
| 17 |
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
|
Toledo-Romani, María Eugenia
|
|
|
|
11 |
p. 760-773.e5
|
artikel
|
| 18 |
Selinexor: Changing the paradigm in patients with TP53 wild-type endometrial cancer?
|
Gouda, Mohamed A.
|
|
|
|
11 |
p. 752-754
|
artikel
|
| 19 |
Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatment
|
Sponagel, Jasmin
|
|
|
|
11 |
p. 792-811.e12
|
artikel
|
| 20 |
Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activation
|
Bowen, Emily E.
|
|
|
|
11 |
p. 761-777.e8
|
artikel
|
| 21 |
Sterile protection against malaria in humans with a monoclonal antibody
|
Dobaño, Carlota
|
|
|
|
11 |
p. 1198-1200
|
artikel
|
| 22 |
Targeting LRG1 boosts immunotherapy
|
Lund, Amanda W.
|
|
|
|
11 |
p. 1195-1197
|
artikel
|
| 23 |
Targeting more precisely: Improving sensitivity to EGFR inhibitors in NSCLC
|
Gower, Arjan
|
|
|
|
11 |
p. 1201-1202
|
artikel
|
| 24 |
Transforming ovarian cancer care by targeting minimal residual disease
|
Jazaeri, Amir A.
|
|
|
|
11 |
p. 755-760
|
artikel
|
| 25 |
Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors
|
Coutinho, Diego F.
|
|
|
|
11 |
p. 774-791.e7
|
artikel
|
Tijdschrift beschrijving